At a White House press conference Monday, President Donald Trump and several officials said the FDA will update drug labels to discourage acetaminophen use during pregnancy, citing a potential link between the common pain reliever and autism. The announcement came despite limited scientific evidence supporting such claims and was presented as part of the administration’s stated effort to address rising autism diagnoses.